121 related articles for article (PubMed ID: 3114340)
1. T6+ and HLA-DR+ cell numbers in epidermis of immunosuppressed renal transplant recipients.
Kelly G; Scheibner A; Murray E; Sheil R; Tiller D; Horvath J
J Cutan Pathol; 1987 Aug; 14(4):202-6. PubMed ID: 3114340
[TBL] [Abstract][Full Text] [Related]
2. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
4. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients.
Viac J; Chardonnet Y; Euvrard S; Chignol MC; Thivolet J
J Dermatol; 1992 Feb; 19(2):67-77. PubMed ID: 1352312
[TBL] [Abstract][Full Text] [Related]
6. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR positive epidermal Langerhans' cells in liver cirrhosis and immunosuppressed liver transplanted patients.
Gilhar A; Enat R; Baruch Y
Acta Derm Venereol; 1994 Mar; 74(2):93-4. PubMed ID: 7911635
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic sun exposure on human Langerhans cell densities.
Czernielewski JM; Masouye I; Pisani A; Ferracin J; Auvolat D; Ortonne JP
Photodermatol; 1988 Jun; 5(3):116-20. PubMed ID: 3262870
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subsets and Langerhans cells in sun-protected and sun-exposed skin of immunosuppressed renal allograft recipients.
Galvão MM; Sotto MN; Kihara SM; Rivitti EA; Sabbaga E
J Am Acad Dermatol; 1998 Jan; 38(1):38-44. PubMed ID: 9448203
[TBL] [Abstract][Full Text] [Related]
10. Class II antigen expression of epidermal Langerhans cells in renal allograft recipients.
Jontell M; Gäbel H; Ohman SC; Brynger H
Transpl Int; 1988 Dec; 1(4):186-9. PubMed ID: 3075481
[TBL] [Abstract][Full Text] [Related]
11. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
12. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
[TBL] [Abstract][Full Text] [Related]
13. Skin cancer and warts in immunosuppressed renal transplant recipients.
Leigh IM; Glover MT
Recent Results Cancer Res; 1995; 139():69-86. PubMed ID: 7597313
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
[TBL] [Abstract][Full Text] [Related]
15. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and morphometric analysis of Langerhans cells in non-exposed skin in renal transplant patients.
Servitje O; Serón D; Ferrer I; Carrera M; Pagerols X; Peyri J
J Cutan Pathol; 1991 Apr; 18(2):106-11. PubMed ID: 1830323
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
Ashworth J; Kahan MC; Breathnach SM
J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
[TBL] [Abstract][Full Text] [Related]
18. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
[TBL] [Abstract][Full Text] [Related]
19. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
20. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
